
Diethyl L-glutamate hydrochloride | CAS:1118-89-4
Diethyl L-glutamate hydrochloride
- Name:Diethyl L-glutamate hydrochloride
- CAS:1118-89-4
- Synonyms:L-Glutamic acid diethyl ester hydrochloride
- Molecular Formula:C9H17NO4.HCl
- Molecular Weight:239.70
- EINESC:214-270-4
Description
Properties
没有数据 | 没有数据 |
---|
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Sigma-Aldrich | View & Download |
TCI | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.Marinez O Sousa et al.Archives of biochemistry and biophysics, 400(1), 7-14 (2002-03-27)
Effect of fucoidan during activation of human plasminogen.V M Doctor et al.Thrombosis research, 79(3), 237-247 (1995-08-01)
Activating effect of the plasminogen activators on plasminogens of different mammalia species.S A Yakovlev et al.Thrombosis research, 79(4), 423-428 (1995-08-15)
Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.M Pantzar et al.Infection and immunity, 66(10), 4976-4980 (1998-09-24)
Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.T Nishino et al.Thrombosis research, 99(6), 623-634 (2000-09-07)
[Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].J Orbe et al.Sangre, 39(4), 261-266 (1994-08-01)
The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.J F Liang et al.Thrombosis research, 97(5), 349-358 (2000-03-10)
Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from Brevibacillus brevis strain FF02B.Sourav Majumdar et al.Biochimie, 103, 50-60 (2014-04-17)
Dual effect of synthetic plasmin substrates on plasminogen activation.K Kolev et al.Biochimica et biophysica acta, 1247(2), 239-245 (1995-03-15)
Effects of wine on plasma fibrinolytic and coagulation systems.H Sumi et al.Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 33(3), 263-272 (1998-08-14)
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis.M Ieko et al.Seminars in thrombosis and hemostasis, 26(1), 85-90 (2000-05-11)
Effects of endothelial cells on activity of staphylokinase.S Ueshima et al.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 7(5), 522-529 (1996-07-01)
Role of plasminogen activator inhibitor - 1 (PAI-1) in regulating the pathogenesis of S. aureus arthritis via plasminogen pathway.Sahin Sultana et al.Immunology letters, 209, 53-66 (2019-03-30)
Development of plasma kallikrein selective inhibitors.Y Okada et al.Biopolymers, 51(1), 41-50 (1999-06-25)
Enhancement of fibrinolytic activity of human plasma in the presence of acetone.K Adamus et al.Scandinavian journal of clinical and laboratory investigation, 54(5), 353-359 (1994-08-01)
Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.M Yamada et al.Veterinary research communications, 21(2), 75-84 (1997-02-01)
Etoposide-mediated depletion of peripheral blood monocytes post s.aureus infection attenuates septic arthritis by modulating macrophage-derived factors responsible for inflammatory destruction.Sahin Sultana et al.Immunology letters, 220, 51-62 (2020-02-08)
Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties.M D Phaneuf et al.Thrombosis and haemostasis, 71(4), 481-487 (1994-04-01)
Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clots.M E Carr et al.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 7(2), 109-113 (1996-03-01)
[Streptokinase: correlation between different methods of biological evaluation].L M Oliva et al.Sangre, 43(3), 231-235 (1998-09-19)
Antiplatelet and antithrombotic activity of a fibrin(ogen)olytic protease from Bacillus cereus strain FF01.Sourav Majumdar et al.International journal of biological macromolecules, 79, 477-489 (2015-05-13)
The rate of plasmin formation after in vitro clotting is inversely related to lipoprotein(a) plasma levels.R Testa et al.International journal of clinical & laboratory research, 29(3), 128-132 (1999-12-11)
A novel assay to measure plasminogen activation capacity in tissue culture on concanavalin A-sepharose.G Spencer-Green Thrombosis research, 74(6), 665-672 (1994-06-15)
Genetic modification of the streptokinase gene to study the interaction of streptokinase with plasminogen.S Lizano et al.Developments in biological standardization, 85, 195-198 (1995-01-01)
Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).L C Petersen European journal of biochemistry, 245(2), 316-323 (1997-04-15)
Effect of individual caseins on plasminogen activation by bovine urokinase-type and tissue-type plasminogen activators.I Politis et al.Journal of dairy science, 78(3), 484-490 (1995-03-01)
Gossypol-induced inhibition of plasminogen activator activity in human and ovine acrosomal extract.I A Taitzoglou et al.Andrologia, 31(6), 355-359 (2000-01-22)
Effects of native and denatured whey proteins on plasminogen activator activity.K M Rippel et al.Journal of dairy science, 87(8), 2344-2350 (2004-08-26)
Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.I A Taitzoglou et al.Reproduction (Cambridge, England), 121(1), 131-137 (2001-02-28)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!